Dice Therapeutics Inc
(DICE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | |
| Sales | 0 | 225 |
| Gross Profit | N/A | 225 |
| Operating Expenses | 0 | 6,207 |
| Operating Income | N/A | -5,982 |
| Interest Expense | 0 | 3 |
| Other Income | 0 | -31 |
| Pre-tax Income | 0 | -6,016 |
| Net Income Continuous | N/A | -6,016 |
| Net Income | $N/A | $-6,016 |
| EPS Basic Total Ops | N/A | -2.68 |
| EPS Basic Continuous Ops | N/A | -2.68 |
| EPS Diluted Total Ops | N/A | -2.68 |
| EPS Diluted Continuous Ops | N/A | -2.68 |
| EBITDA(a) | $N/A | $-5,982 |